Pacira BioSciences, Inc. Quarterly Costs and Expenses in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Pacira BioSciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
  • Pacira BioSciences, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $308M, a 111% increase year-over-year.
  • Pacira BioSciences, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $760M, a 22.3% increase year-over-year.
  • Pacira BioSciences, Inc. annual Costs and Expenses for 2023 was $587M, a 3.21% decline from 2022.
  • Pacira BioSciences, Inc. annual Costs and Expenses for 2022 was $607M, a 34.4% increase from 2021.
  • Pacira BioSciences, Inc. annual Costs and Expenses for 2021 was $452M, a 17.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $760M $308M +$162M +111% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $598M $150M +$20.2M +15.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $578M $154M -$9.53M -5.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $587M $148M -$33.8M -18.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $621M $146M +$28K +0.02% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $621M $130M -$8.59M -6.21% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $630M $163M +$22.8M +16.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $607M $182M +$26.9M +17.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $580M $146M +$49.9M +51.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $530M $138M +$37.4M +37.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $493M $141M +$41M +41.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $452M $155M +$42.8M +38.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $409M $96.3M -$3.58M -3.58% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $412M $101M +$18.1M +21.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $394M $99.6M +$11M +12.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $383M $112M -$8.52M -7.06% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $392M $99.9M -$2.41M -2.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $394M $82.7M -$14.7M -15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $409M $88.6M -$1.64M -1.82% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $411M $121M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $102M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $97.3M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $90.2M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.